Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study

Author:

Schernthaner, G.; Rosas-Guzman, J.; Dotta, F.; Guerci, B.; Simo, R.; Festa, A.; Kiljanski, J.; Zhou, M.; Gallwitz, B.

Tübinger Autor(en):

Published in:

Diabetes Obesity & Metabolism (2015), Bd. 17, H. 7, S. 689-698

Verlagsangabe:

Wiley - Blackwell

Language:

English

Full text:

ISSN:

1462-8902

DDC Classifikation:

610 - Medicine and health

Dokumentart:

Article

This item appears in the following Collection(s)